Acorah Software Products - Accounts Production 15.0.600 false true 30 November 2022 1 December 2021 false 1 December 2022 30 November 2023 30 November 2023 8760058 Mrs Fadak Hussain Ali Dr Basil Almahdi iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 8760058 2022-11-30 8760058 2023-11-30 8760058 2022-12-01 2023-11-30 8760058 frs-core:CurrentFinancialInstruments 2023-11-30 8760058 frs-core:FurnitureFittings 2023-11-30 8760058 frs-core:FurnitureFittings 2022-12-01 2023-11-30 8760058 frs-core:FurnitureFittings 2022-11-30 8760058 frs-core:ShareCapital 2023-11-30 8760058 frs-core:RetainedEarningsAccumulatedLosses 2022-12-01 2023-11-30 8760058 frs-core:RetainedEarningsAccumulatedLosses 2023-11-30 8760058 frs-bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 8760058 frs-bus:FilletedAccounts 2022-12-01 2023-11-30 8760058 frs-bus:SmallEntities 2022-12-01 2023-11-30 8760058 frs-bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 8760058 frs-bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 8760058 frs-bus:Director1 2022-12-01 2023-11-30 8760058 frs-bus:Director2 2022-12-01 2023-11-30 8760058 frs-countries:EnglandWales 2022-12-01 2023-11-30 8760058 2021-11-30 8760058 2022-11-30 8760058 2021-12-01 2022-11-30 8760058 frs-core:CurrentFinancialInstruments 2022-11-30 8760058 frs-core:ShareCapital 2021-11-30 8760058 frs-core:ShareCapital 2022-11-30 8760058 frs-core:RetainedEarningsAccumulatedLosses 2021-12-01 2022-11-30 8760058 frs-core:RetainedEarningsAccumulatedLosses frs-core:PreviouslyStatedAmount 2021-11-30 8760058 frs-core:RetainedEarningsAccumulatedLosses 2022-11-30
Registered number: 8760058
MAWADDAH MEDICAL LTD
Unaudited Financial Statements
For The Year Ended 30 November 2023
ZA LTD
FMAAT AND FFA
Contents
Page
Accountants' Report 1
Balance Sheet 2—3
Statement of Changes in Equity 4
Notes to the Financial Statements 5—6
Page 1
Accountants' Report
Report of the Accountant to the directors of MAWADDAH MEDICAL LTD
These financial statements have been prepared in accordance with our terms of engagement and in order to assist you to fulfil your duties under the Companies Acts that relate to preparing the financial statements of the company for the year ended 30 November 2023.
We have prepared these financial statements based on the accounting records, information and explanations provided by you. We do not express any opinion on the financial statements.
On the Balance Sheet you have acknowledged your duties under the prevailing Companies Acts to ensure that the company keeps adequate accounting records and prepares financial statements that give “a true and fair view”.
You have determined that the company is exempt from the statutory requirement for an audit for this accounting year. Therefore, the financial statements are unaudited.
The financial statements are provided exclusively to the director for the limited purpose mentioned above, and may not be used or relied upon for any other purpose or by any other person, and we shall not be liable for any other usage or reliance.
Signed
ZA Ltd
28/08/2024
ZA LTD
FMAAT AND FFA
Page 1
Page 2
Balance Sheet
Registered number: 8760058
2023 2022
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 7,144 6,901
7,144 6,901
CURRENT ASSETS
Cash at bank and in hand 37,013 14,054
37,013 14,054
Creditors: Amounts Falling Due Within One Year 5 (19,737 ) (11,679 )
NET CURRENT ASSETS (LIABILITIES) 17,276 2,375
TOTAL ASSETS LESS CURRENT LIABILITIES 24,420 9,276
NET ASSETS 24,420 9,276
CAPITAL AND RESERVES
Called up share capital 6 1,000 1,000
Profit and Loss Account 23,420 8,276
SHAREHOLDERS' FUNDS 24,420 9,276
Page 2
Page 3
For the year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mrs Fadak Hussain Ali
Director
Dr Basil Almahdi
Director
28/08/2024
The notes on pages 5 to 6 form part of these financial statements.
Page 3
Page 4
Statement of Changes in Equity
Share Capital Profit and Loss Account Total
£ £ £
As at 1 December 2021 1,000 1,841 2,841
Profit for the year and total comprehensive income - 46,435 46,435
Dividends paid - (40,000) (40,000)
As at 30 November 2022 and 1 December 2022 1,000 8,276 9,276
Profit for the year and total comprehensive income - 65,144 65,144
Dividends paid - (50,000) (50,000)
As at 30 November 2023 1,000 23,420 24,420
Page 4
Page 5
Notes to the Financial Statements
1. General Information
MAWADDAH MEDICAL LTD is a private company, limited by shares, incorporated in England & Wales, registered number 8760058 . The registered office is 70 Stag Lane, Edgware, Middlesex, HA8 5JY.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements are prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (effective April 2008).
2.2. Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of trade discounts.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Fixtures & Fittings 25% on reducing balance
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the year was:
2023 2022
Office and administration 1 1
1 1
Page 5
Page 6
4. Tangible Assets
Fixtures & Fittings
£
Cost
As at 1 December 2022 25,398
Additions 2,624
As at 30 November 2023 28,022
Depreciation
As at 1 December 2022 18,497
Provided during the period 2,381
As at 30 November 2023 20,878
Net Book Value
As at 30 November 2023 7,144
As at 1 December 2022 6,901
5. Creditors: Amounts Falling Due Within One Year
2023 2022
£ £
Corporation tax 18,203 10,179
Accruals and deferred income 1,534 1,500
19,737 11,679
6. Share Capital
2023 2022
£ £
Allotted, Called up and fully paid 1,000 1,000
7. Dividends
2023 2022
£ £
On equity shares:
Final dividend paid 50,000 40,000
Page 6